Related Experiment Video
Updated: Aug 9, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Phaeochromocytoma and pregnancy: a case report
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|September 10, 1977
Summary
This case report highlights maternal death due to phaeochromocytoma, emphasizing diagnostic challenges and poor outcomes. It warns against using sympathomimetic agents in pregnant patients with this condition.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Pathology
Background:
- Phaeochromocytoma, a rare neuroendocrine tumor, poses significant risks during pregnancy.
- Maternal mortality associated with phaeochromocytoma remains a critical concern due to diagnostic complexities.
Observation:
- A case of maternal death is presented, directly linked to undiagnosed or poorly managed phaeochromocytoma.
- The clinical presentation mimicked common pregnancy complications, leading to diagnostic delays.
Findings:
- Diagnostic difficulty in identifying phaeochromocytoma during pregnancy is a major contributing factor to adverse outcomes.
- Both maternal and fetal prognoses are exceedingly poor when phaeochromocytoma is present and inadequately managed.
Implications:
- This case underscores the importance of considering phaeochromocytoma in pregnant patients with unexplained hypertension or cardiovascular instability.
- Clinicians must exercise extreme caution regarding the use of sympathomimetic agents, which can precipitate life-threatening hypertensive crises in patients with phaeochromocytoma.
